187 related articles for article (PubMed ID: 33792800)
1. Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial.
Wang XS; Shi Q; Mendoza TR; Garcia-Gonzalez A; Chen TY; Kamal M; Chen TH; Heijnen C; Orlowski RZ; Cleeland CS
Support Care Cancer; 2021 Oct; 29(10):6099-6107. PubMed ID: 33792800
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer.
Kamal M; Wang XS; Shi Q; Mendoza T; Garcia-Gonzalez A; Bokhari RH; Cleeland CS; Fogelman DR
J Pain Symptom Manage; 2020 May; 59(5):1052-1058.e1. PubMed ID: 31982605
[TBL] [Abstract][Full Text] [Related]
3. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial.
Wang XS; Shi Q; Bhadkamkar NA; Cleeland CS; Garcia-Gonzalez A; Aguilar JR; Heijnen C; Eng C
J Pain Symptom Manage; 2019 Oct; 58(4):662-671. PubMed ID: 31254639
[TBL] [Abstract][Full Text] [Related]
4. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial.
Wang XS; Shi Q; Mendoza T; Lin S; Chang JY; Bokhari RH; Lin HK; Garcia-Gonzalez A; Kamal M; Cleeland CS; Liao Z
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):100-107. PubMed ID: 31627177
[TBL] [Abstract][Full Text] [Related]
5. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial.
Gunn GB; Mendoza TR; Garden AS; Wang XS; Shi Q; Morrison WH; Frank SJ; Phan J; Fuller CD; Chambers MS; Hanna EY; Lu C; Rosenthal DI; Cleeland CS
Support Care Cancer; 2020 Jan; 28(1):261-269. PubMed ID: 31037378
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma.
Wang XS; Shi Q; Williams LA; Shah ND; Mendoza TR; Cohen EN; Reuben JM; Cleeland CS; Orlowski RZ
Leuk Lymphoma; 2015 May; 56(5):1335-41. PubMed ID: 25248883
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation.
Wang XS; Shi Q; Shah ND; Heijnen CJ; Cohen EN; Reuben JM; Orlowski RZ; Qazilbash MH; Johnson VE; Williams LA; Mendoza TR; Cleeland CS
Clin Cancer Res; 2014 Mar; 20(5):1366-74. PubMed ID: 24423611
[TBL] [Abstract][Full Text] [Related]
8. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.
Shi Q; Wang XS; Li G; Shah ND; Orlowski RZ; Williams LA; Mendoza TR; Cleeland CS
Cancer; 2015 Apr; 121(7):1138-46. PubMed ID: 25469832
[TBL] [Abstract][Full Text] [Related]
9. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator.
Vanelderen P; Van Zundert J; Kozicz T; Puylaert M; De Vooght P; Mestrum R; Heylen R; Roubos E; Vissers K
Anesthesiology; 2015 Feb; 122(2):399-406. PubMed ID: 25373391
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial.
Mendoza TR; Hong DS; Peterson CB; Stephen B; Dumbrava E; Pant S; Tsimberidou AM; Yap TA; Sheshadri A; Altan M; George G; Castillo L; Rodriguez E; Gong J; Subbiah V; Janku F; Fu S; Piha-Paul SA; Ahnert JR; Karp DD; Cleeland C; Meric-Bernstam F; Naing A
Sci Rep; 2022 Aug; 12(1):14367. PubMed ID: 35999229
[TBL] [Abstract][Full Text] [Related]
11. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial.
Deng G; Giralt S; Chung DJ; Landau H; Siman J; Search B; Coleton M; Vertosick E; Shapiro N; Chien C; Wang XS; Cassileth B; Mao JJ
Support Care Cancer; 2018 Feb; 26(2):657-665. PubMed ID: 28920142
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. Symptom burden and its functional impact in patients with "symptomatic" relapsed or refractory multiple myeloma.
Kamal M; Wang XS; Shi Q; Zyczynski TM; Davis C; Williams LA; Lin HK; Garcia-Gonzalez A; Cleeland CS; Orlowski R
Support Care Cancer; 2021 Jan; 29(1):467-475. PubMed ID: 32390093
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial.
Fekadu A; Mesfin M; Medhin G; Alem A; Teferra S; Gebre-Eyesus T; Seboxa T; Assefa A; Hussein J; Lemma MT; Borba C; Henderson DC; Hanlon C; Shibre T
Trials; 2013 Nov; 14():406. PubMed ID: 24279305
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.
van de Donk NW; van der Holt B; Minnema MC; Vellenga E; Croockewit S; Kersten MJ; von dem Borne PA; Ypma P; Schaafsma R; de Weerdt O; Klein SK; Delforge M; Levin MD; Bos GM; Jie KG; Sinnige H; Coenen JL; de Waal EG; Zweegman S; Sonneveld P; Lokhorst HM
Lancet Haematol; 2018 Oct; 5(10):e479-e492. PubMed ID: 30290905
[TBL] [Abstract][Full Text] [Related]
16. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.
Wang XS; Williams LA; Krishnan S; Liao Z; Liu P; Mao L; Shi Q; Mobley GM; Woodruff JF; Cleeland CS
Brain Behav Immun; 2012 Jul; 26(5):699-705. PubMed ID: 22251605
[TBL] [Abstract][Full Text] [Related]
17. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
18. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Dimopoulos MA; Gay F; Schjesvold F; Beksac M; Hajek R; Weisel KC; Goldschmidt H; Maisnar V; Moreau P; Min CK; Pluta A; Chng WJ; Kaiser M; Zweegman S; Mateos MV; Spencer A; Iida S; Morgan G; Suryanarayan K; Teng Z; Skacel T; Palumbo A; Dash AB; Gupta N; Labotka R; Rajkumar SV;
Lancet; 2019 Jan; 393(10168):253-264. PubMed ID: 30545780
[TBL] [Abstract][Full Text] [Related]
19. Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy.
Hovey E; de Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft P; Abdi E; Lloyd A;
Support Care Cancer; 2014 May; 22(5):1233-42. PubMed ID: 24337761
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
